Cadre (NYSE:CDRE) Price Target Lowered to $37.00 at Roth Mkm

Cadre (NYSE:CDRE) had its target price cut by stock analysts at Roth Mkm from $39.00 to $37.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Roth Mkm’s price objective would indicate a potential upside of 9.73% from the stock’s current price.

Cadre Trading Down 9.2 %

CDRE stock traded down $3.43 during midday trading on Thursday, hitting $33.72. The stock had a trading volume of 158,106 shares, compared to its average volume of 227,816. The firm has a market cap of $1.37 billion, a P/E ratio of 33.11, a price-to-earnings-growth ratio of 2.09 and a beta of 1.30. The company has a current ratio of 3.17, a quick ratio of 2.14 and a debt-to-equity ratio of 0.66. Cadre has a 1-year low of $28.14 and a 1-year high of $40.28. The business has a fifty day moving average price of $36.97 and a two-hundred day moving average price of $34.92.

Cadre (NYSE:CDRE) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.02. Cadre had a net margin of 7.55% and a return on equity of 17.45%. The business had revenue of $109.41 million during the quarter, compared to the consensus estimate of $126.27 million. During the same period in the prior year, the firm posted $0.29 EPS. The firm’s quarterly revenue was down 12.6% compared to the same quarter last year. On average, sell-side analysts predict that Cadre will post 1.04 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the business. Price T Rowe Associates Inc. MD grew its position in Cadre by 32.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 460,500 shares of the company’s stock valued at $16,671,000 after buying an additional 113,722 shares during the period. Lisanti Capital Growth LLC lifted its holdings in Cadre by 127.5% during the first quarter. Lisanti Capital Growth LLC now owns 145,915 shares of the company’s stock valued at $5,282,000 after purchasing an additional 81,780 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Cadre by 21.2% during the first quarter. Vanguard Group Inc. now owns 1,180,212 shares of the company’s stock valued at $42,724,000 after purchasing an additional 206,564 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in Cadre by 28.3% during the second quarter. Bank of New York Mellon Corp now owns 161,036 shares of the company’s stock valued at $5,404,000 after purchasing an additional 35,476 shares in the last quarter. Finally, Old West Investment Management LLC lifted its holdings in Cadre by 59.9% during the second quarter. Old West Investment Management LLC now owns 220,211 shares of the company’s stock valued at $7,390,000 after purchasing an additional 82,501 shares in the last quarter. 43.95% of the stock is owned by hedge funds and other institutional investors.

Cadre Company Profile

Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.